Oxidative stress and fatigue in systemic lupus erythematosus

Lupus

Volumn 21, Issue 9, 2012, Pages 984-992

  Segal, B M ^a   Thomas, W ^a   Zhu, X ^b   Diebes, A ^a   McElvain, G ^c   Baechler, E ^a   Gross, M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c STANFORD UNIVERSITY   (United States)

Author keywords

fatigue; oxidative stress; Systemic lupus erythematosus (SLE)

Indexed keywords

ISOPROSTANE DERIVATIVE;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DISEASE ACTIVITY; ETHNICITY; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OXIDATIVE STRESS; PAIN; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROFILE OF SOMATIC FATIGUE; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RATING SCALE; SYSTEMIC LUPUS ERYTHEMATOSUS; VISUAL ANALOG SCALE;

ADULT; BODY MASS INDEX; F2-ISOPROSTANES; FATIGUE; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS;

EID: 84863889877     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312444772     Document Type: Article

References (46)

1. Liang MH, Rogers M, Larson M, et al. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arth Rheum. 1984 ; 27: 13-19 (Pubitemid 14176531)
2. Zonana-Nacach A, Roseman JM, McGwin G, et al. Systemic lupus erythematosus in three ethnic groups. VI: Factors associated with fatigue within 5 years of criteria diagnosis. LUMINA Study Group. Lupus in Minority populations: Nature vs Nurture. Lupus. 2000 ; 9: 101-109 (Pubitemid 30171106)
3. Bruce IN, Hallet DC, Gladman DD, Urowitz MB. Factors associated with fatigue in patients with systemic lupus erythematosus. Ann Rheum Dis. 1999 ; 58: 379-381 (Pubitemid 29276997)
4. Kozora E, Ellison MC, West S. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. Arth Rheum. 2006 ; 55: 628-635 (Pubitemid 44289884)
5. Iaboni A, Ibanez D, Gladman DD, Urowitz MB, Moldofsky H. Fatigue in systemic lupus erythematosus: contributions of disordered sleep, sleepiness, and depression. J Rheumatol. 2006 ; 33: 2453-2457 (Pubitemid 46067825)
6. Da Costa D, Dritsa M, Bernatsky S, et al. Dimensions of fatigue in systemic lupus erythematosus: relationship to disease status and behavioral and psychosocial factors. J Rheumatol. 2006 ; 33: 1282-1288 (Pubitemid 44025141)
7. Oeser A, Chung CP, Asanuma Y, Avalos I, Stein CM. Obesity is an independent contributor to functional capacity and inflammation in systemic lupus erythematosus. Arth Rheum. 2005 ; 52: 3651-3659 (Pubitemid 41612237)
8. Keyser RE, Rus V, Cade WT, Kalappa N, Flores RH, Handwerger BS. Evidence for aerobic insufficiency in women with systemic lupus erythematosus. Arth Rheum. 2003 ; 49: 16-22 (Pubitemid 36286125)
9. Houghton KM, Tucker LB, Potts JE, McKenzie DC. Fitness, fatigue, disease activity, and quality of life in pediatric lupus. Arth Rheum. 2008 ; 59: 537-545 (Pubitemid 351563537)
10. Tench C, Bentley D, Vleck V, McCurdie I, White P, D'Cruz D. Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol. 2002 ; 29: 474-481 (Pubitemid 34202814)
11. Daltroy LH, Robb-Nicholson C, Iversen MD, Wright EA, Liang MH. Effectiveness of minimally supervised home aerobic training in patients with systemic rheumatic disease. Br J Rheumatol. 1995 ; 34: 1064-1069 (Pubitemid 26013510)
12. Robb-Nicholson LC, Daltroy L, Eaton H, et al. Effects of aerobic conditioning in lupus fatigue: a pilot study. Br J Rheumatol. 1989 ; 28: 500-505 (Pubitemid 20004021)
13. Evans JL, Maddus BA, Grodsky GM. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?. Diabetes. 2003 ; 52: 1-8 (Pubitemid 36042100)
14. Morrow JD, Awad JA, Boss HJ, Blair IA, Roberts LJ. Non-cyclooxygenase- derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A. 1992 ; 89: 10721-10725
15. Praticò D, Rokach J, Lawson J, FitzGerald GA. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem Phys Lipids. 2004 ; 128: 165-171 (Pubitemid 38167385)
16. Milne GL, Sanchez SC, Musiek ES, Morrow JD. Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc. 2007 ; 2: 221-226 (Pubitemid 47040087)
17. Leitinger N. The role of phospholipid oxidation products in inflammatory and autoimmune disease: evidence from animal models and in humans. Subcell Biochem. 2008 ; 49: 325-350
18. Stephens JW, Khanolkar MP, Bain SC. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis. 2009 ; 202: 321-329
19. Ames PR, Alves J, Murat I, Isenberg DA, Nourooz-Zadeh J. Oxidative stress in systemic lupus erythematosus and allied conditions with vascular involvement. Rheumatology. 1999 ; 38: 529-534 (Pubitemid 29504838)
20. Iuliano L, Praticò D, Ferro D, et al. Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies. Blood. 1997 ; 90: 3931-3931
21. Frostegard J, Svenungsson E, Wu R, et al. Lipid peroxidation is enhanced in patients with systemic lupus erythematosus and is associated with arterial and renal disease manifestations. Arthritis Rheum. 2005 ; 52: 192-200 (Pubitemid 40129248)
22. Alves JD, Ames PR. Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome. Immunobiology. 2003 ; 207: 23-28 (Pubitemid 36285092)
23. Fulle S, Pietrangelo T, Mancinelli R, Saggini R, Fano G. Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis. J Muscle Res Cell Motil. 2007 ; 28: 355-362
24. Jammes Y, Steinberg JG, Mambrini O, Bregeon F, Delliaux S. Chronic fatigue syndrome: assessment of increased oxidative stress and altered muscle excitability in response to incremental exercise. J Intern Med. 2005 ; 257: 299-310 (Pubitemid 40342133)
25. Richards R, Wang L, Jelinek H. Erythrocyte oxidative damage in chronic fatigue syndrome. Arch Med Res. 2007 ; 38: 94-98 (Pubitemid 44894610)
26. Chung CP, Titova D, Oeser A, et al. Oxidative stress in fibromyalgia and its relationship to symptoms. Clin Rheumatology. 2009 ; 28: 435-438
27. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. J Affect Disord. 2010 ; 125: 287-294
28. Avalos I, Chung CP, Oeser A, et al. Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms. Lupus. 2007 ; 16: 195-200 (Pubitemid 46506597)
29. Halliwell B, Lee C. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid Redox Signal. 2010 ; 13: 145-156
30. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arth Rheum. 1997 ; 40: 1725-1725
31. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arth Rheum. 1996 ; 39: 363-369 (Pubitemid 26085211)
32. Petri M, Hellmann D, Hochberg M. Validity and reliability of lupus activity measures in the routine clinic setting. J Rheumatol. 1992 ; 19: 53-59
33. Morrow JD, Roberts LJ. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Meth Enzymol. 1999 ; 300: 3-12 (Pubitemid 28500576)
34. Gross M, Steffes M, Jacobs DR, et al. Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study. Clin Chem. 2005 ; 51: 125-131 (Pubitemid 40024021)
35. Radloff LS. The Centers for Epidemiologic Studies Depression Scale (CES-D): a self-report depression scale for research in the general population. Appl Psychol Meas. 1977 ; 1: 385-401
36. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol. 1989 ; 46: 1121-1123 (Pubitemid 19246303)
37. Bowman SJ, Booth DA, Platts RG, UK Sjogren's Interest Group. Measurement of fatigue and discomfort in primary Sjogren's syndrome using a new questionnaire tool. Rheumatology (Oxford). 2004 ; 43: 758-764 (Pubitemid 38807434)
38. Wang G, Pierangeli SS, Papalardo E, Ansari GAS, Khan MF. Markers of oxidative and nitrosative stress in systemic lupus erythematosus: correlation with disease activity. Arth Rheum. 2010 ; 62: 2064-2072
39. Shah D, Aggarwal A, Bhatnagar A, Kiran R, Wanchu A. Association between T lymphocyte sub-sets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus. Free Radic Res. 2011 ; 45: 559-567
40. Morgan PE, Sturgess AD, Davies MJ. Evidence for chronically elevated serum protein oxidation in systemic lupus erythematosus patients. Free Radic Res. 2009 ; 43: 117-127
41. Gramignano G, Lusso MR, Madeddu C, et al. Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition. 2006 ; 22: 136-145 (Pubitemid 43188803)
42. Dimopoulos N, Piperi C, Psarra V, Lea RW, Kalofoutis A. Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression. Psychiatry Res. 2008 ; 161: 59-66
43. Bagis S, Tamer L, Sahin G, et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder?. Rheumatol Int. 2005 ; 25: 188-190 (Pubitemid 40576783)
44. Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med. 2005 ; 39: 584-589 (Pubitemid 41112100)
45. Nikolaidis MG, Kyparos A, Vrabas IS. F2-isoprostane formation, measurement and interpretation: the role of exercise. Prog Lipid Res. 2011 ; 50: 89-103
46. Shah D, Kiran R, Wanchu A, Bhatnagar A. Oxidative stress in systemic lupus erythematosus: relationship to Th1 cytokine and disease activity. Immunol Lett. 2010 ; 129: 7-12